Yaguang Bi

Yaguang Bi

Auto-generated profile, based on publicly available information

Yaguang Bi

Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2021 in Nature Reviews Cardiology
Verified
Journal Article
Closed access
PDF file
JRJun Ren
Jun Ren
YBYaguang Bi
Yaguang Bi
JSJames R. Sowers
James R. Sowers
CHClaudio Hetz
Claudio Hetz
YZYingmei Zhang
Yingmei Zhang

7 January 2022 in Pharmacological Research
Verified
Journal Article
Open access
AAAmir Ajoolabady
Amir Ajoolabady
YBYaguang Bi
Yaguang Bi
DMDavid J. McClements
David J. McClements
Gregory LipGregory Lip
Gregory Lip
DRDes Richardson
Des Richardson
JRJun Ren
Jun Ren
Atherosclerosis refers to a unique form of chronic proinflammatory anomaly of the vasculature, presented as rupture-prone or occlusive lesions in arteries. In advanced stages, atherosclerosis leads to the onset and development of multiple cardiovascular diseases with lethal consequences. Inflammatory cytokines in atherosclerotic lesions contribute to the exacerbation of atherosclerosis. Pharmacotherapies targeting dyslipidemia, hypercholesterolemia, and neutralizing inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-17, and IL-12/23) have displayed proven promises although contradictory results. Moreover, adjuvants such as melatonin, a pluripotent agent with proven anti-inflammatory, anti-oxidative and neuroprotective properties, also display potentials in alleviating cytokine secretion in macrophages through mitophagy activation. Here, we share our perspectives on this concept and present melatonin-based therapeutics as a means to modulate mitophagy in macrophages and, thereby, ameliorate atherosclerosis.

22 August 2022 in JACC: Basic To Translational Science
Verified
Journal Article
Open access
NWNe Wu
Ne Wu
YBYaguang Bi
Yaguang Bi
AAAmir Ajoolabady
Amir Ajoolabady
FYFei You
Fei You
JSJames R Sowers
James R Sowers
JRJun Ren
Jun Ren
• Mitochondrial Ca2+ overload contributes to obesity-induced cardiac injury. • Parkin deletion aggravates obesity cardiomyopathy independent of systemic effects. • Parkin regulates VDAC1 degradation, but not other mitochondrial Ca2+ transporters. • Parkin expression or VDAC1 inhibition rescues cardiomyocyte contractile defect.